KBC Group NV trimmed its position in shares of MetLife, Inc. (NYSE:MET – Free Report) by 44.1% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,658,765 shares of the financial services provider’s stock after selling 1,306,102 shares during the quarter. KBC Group NV owned 0.24% of MetLife worth $136,815,000 at the end of the most recent reporting period.
A number of other large investors have also recently made changes to their positions in the business. Carmichael Hill & Associates Inc. lifted its stake in MetLife by 131.9% in the third quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 186 shares during the last quarter. Wolff Wiese Magana LLC raised its holdings in shares of MetLife by 374.3% in the 3rd quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock valued at $29,000 after acquiring an additional 277 shares in the last quarter. Fortitude Family Office LLC increased its position in shares of MetLife by 177.3% in the third quarter. Fortitude Family Office LLC now owns 416 shares of the financial services provider’s stock worth $34,000 after purchasing an additional 266 shares during the last quarter. Bank & Trust Co bought a new stake in MetLife during the second quarter valued at approximately $39,000. Finally, Crewe Advisors LLC grew its stake in MetLife by 602.5% in the 2nd quarter. Crewe Advisors LLC now owns 562 shares of the financial services provider’s stock worth $39,000 after buying an additional 482 shares in the last quarter. 89.81% of the stock is owned by institutional investors.
Analyst Ratings Changes
Several analysts have recently weighed in on the stock. Citigroup raised their price objective on shares of MetLife from $83.00 to $89.00 and gave the company a “buy” rating in a research report on Tuesday, July 23rd. Piper Sandler raised their price target on MetLife from $85.00 to $92.00 and gave the company an “overweight” rating in a research report on Wednesday, October 2nd. Barclays cut their price objective on MetLife from $91.00 to $90.00 and set an “overweight” rating for the company in a report on Thursday, October 31st. Morgan Stanley reduced their price objective on MetLife from $86.00 to $85.00 and set an “overweight” rating on the stock in a research report on Monday, August 19th. Finally, StockNews.com upgraded MetLife from a “hold” rating to a “buy” rating in a research report on Tuesday. Fourteen investment analysts have rated the stock with a buy rating, According to MarketBeat.com, the company has a consensus rating of “Buy” and an average target price of $88.46.
MetLife Stock Down 0.2 %
NYSE MET opened at $82.02 on Thursday. MetLife, Inc. has a 1 year low of $61.16 and a 1 year high of $86.94. The stock has a market capitalization of $56.79 billion, a PE ratio of 16.54, a PEG ratio of 0.75 and a beta of 1.05. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.16 and a quick ratio of 0.16. The business’s 50-day moving average is $81.21 and its 200 day moving average is $75.38.
MetLife Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Tuesday, November 5th will be issued a dividend of $0.545 per share. The ex-dividend date of this dividend is Tuesday, November 5th. This represents a $2.18 dividend on an annualized basis and a dividend yield of 2.66%. MetLife’s dividend payout ratio is presently 43.95%.
About MetLife
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Articles
- Five stocks we like better than MetLife
- How to Calculate Return on Investment (ROI)
- Shopify Stock Rally Continues: Why the Growth Story Isn’t Over
- Where to Find Earnings Call Transcripts
- Tariff Troubles: 3 Stocks Planning Higher Prices
- How to Effectively Use the MarketBeat Ratings Screener
- Mercer Near Rock Bottom: Is This High-Yield Play Set to Soar?
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.